AD-104
/ Yuhan Corp
- LARVOL DELTA
Home
Next
Prev
1 to 4
Of
4
Go to page
1
August 01, 2024
A Study to Assess the Safety and Pharmacokinetics of AD-104-A
(clinicaltrials.gov)
- P1 | N=32 | Completed | Sponsor: Addpharma Inc. | Recruiting ➔ Completed | Trial completion date: Dec 2024 ➔ Apr 2024
Trial completion • Trial completion date • Dyslipidemia • Renal Disease
February 16, 2024
A Study to Assess the Safety and Pharmacokinetics of AD-104-A
(clinicaltrials.gov)
- P1 | N=32 | Recruiting | Sponsor: Addpharma Inc. | Trial completion date: Dec 2023 ➔ Dec 2024 | Trial primary completion date: Nov 2023 ➔ May 2024
Trial completion date • Trial primary completion date • Dyslipidemia • Renal Disease
July 21, 2023
A Study to Assess the Safety and Pharmacokinetics of AD-104-A
(clinicaltrials.gov)
- P1 | N=32 | Recruiting | Sponsor: Addpharma Inc. | Not yet recruiting ➔ Recruiting
Enrollment open • Dyslipidemia • Renal Disease
January 30, 2023
A Study to Assess the Safety and Pharmacokinetics of AD-104-A
(clinicaltrials.gov)
- P1 | N=32 | Not yet recruiting | Sponsor: Addpharma Inc.
New P1 trial • Dyslipidemia • Renal Disease
1 to 4
Of
4
Go to page
1